AnalystsMatthew CaufieldMatthew Caufield's Stock Forecasts
AnalystsMatthew Caufield
Analyst Ranking
Top 18%
#904 out of 5177 analysts
Average Return
+5.77%
Win Rate
41%68 out of 164
Risk vs Reward
Poor
Good
Matthew Caufield's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Phathom Pharmaceuticals IncPHAT | +442.75% | $2.76 | $14.98 | 2025-05-01 - 2026-01-15 | Buy |
Zenas Biopharma IncZBIO | +271.61% | $8.77 | $32.59 | 2024-12-15 - 2025-12-15 | Buy |
Mineralys Therapeutics IncMLYS | +252.09% | $13.38 | $47.11 | 2024-11-11 - 2025-11-11 | Buy |
Mineralys Therapeutics IncMLYS | +207.65% | $10.20 | $31.38 | 2025-02-12 - 2026-01-15 | Buy |
Mineralys Therapeutics IncMLYS | +207.32% | $13.38 | $41.12 | 2024-10-30 - 2025-10-30 | Buy |
Matthew Caufield Analyst Color
Get additional color on Matthew Caufield's coverage of popular stocks
Matthew Caufield's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Fibrobiologics IncFBLG | 8 | Buy | $5.00 | +1,379.29% | Reiterates | 15 days ago |
Akebia Therapeutics IncAKBA | 3 | Buy | $6.00 | +347.76% | Reiterates | a month ago |
Adverum Biotechnologies IncADVM | 8 | Hold | $5.00 | +14.68% | Downgrades | 2 months ago |
Kodiak Sciences IncKOD | 7 | Buy | $26.00 | -2.62% | Maintains | 2 months ago |
Immunic IncIMUX | 6 | Buy | $8.00 | +1,151.96% | Maintains | 2 months ago |
Mineralys Therapeutics IncMLYS | 13 | Buy | $56.00 | +78.46% | Maintains | 2 months ago |
Phathom Pharmaceuticals IncPHAT | 11 | Buy | $26.00 | +73.56% | Maintains | 3 months ago |
Tarsus Pharmaceuticals IncTARS | 2 | Buy | $88.00 | +19.48% | Maintains | 3 months ago |
Zenas Biopharma IncZBIO | 4 | Buy | $30.00 | +50.53% | Reiterates | 3 months ago |
Diamedica Therapeutics IncDMAC | 7 | Buy | $12.00 | +40.52% | Reiterates | 5 months ago |
Lyra Therapeutics IncLYRA | 8 | Hold | $16.00 | +722.62% | Reiterates | 5 months ago |
Lenz Therapeutics IncLENZ | 7 | Buy | $56.00 | +208.71% | Maintains | 6 months ago |
Opus Genetics IncIRD | 13 | Buy | $8.00 | +284.62% | Reiterates | 7 months ago |
Ardelyx IncARDX | 1 | Buy | $10.00 | +42.05% | Assumes | 7 months ago |
Unity Biotechnology IncUNBX | 9 | Hold | $2.00 | +900.00% | Downgrades | 8 months ago |
Optinose IncOPTN | 8 | Hold | $9.00 | -6.25% | Reiterates | 8 months ago |
Aldeyra Therapeutics IncALDX | 13 | Buy | $10.00 | +126.76% | Reiterates | 8 months ago |
Surrozen IncSRZN | 3 | Buy | $32.00 | +60.00% | Reiterates | 8 months ago |
Hillevax IncHLVX | 5 | Hold | $2.00 | -4.31% | Reiterates | 10 months ago |
Opthea LtdOPTEY | 7 | Hold | $2.00 | -41.35% | Downgrades | 10 months ago |
Hyperion Defi IncHYPD | 16 | Hold | $2.00 | -40.30% | Reiterates | 10 months ago |
4d Molecular Therapeutics IncFDMT | 18 | Buy | $36.00 | +373.06% | Reiterates | 10 months ago |
FabrinetFN | 1 | Buy | $28.00 | N/A | Reiterates | 2 years ago |
Iveric Bio IncISEE | 6 | Hold | $40.00 | N/A | Downgrades | 3 years ago |
Oyster Point Pharma IncOYST | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.